CC BY 4.0 · Endoscopy 2024; 56(02): 155-156
DOI: 10.1055/a-2209-3374
E-Videos

Cutting-edge novel device in the treatment of obesity

1   Institute for Clinical and Experimental Medicine, Hepatogastroenterology Department, Prague, Czech Republic
2   Department of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic
,
Jana Selucka
1   Institute for Clinical and Experimental Medicine, Hepatogastroenterology Department, Prague, Czech Republic
,
Katerina Waloszkova
1   Institute for Clinical and Experimental Medicine, Hepatogastroenterology Department, Prague, Czech Republic
,
Marek Buzga
3   Department of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
,
Julius Spicak
1   Institute for Clinical and Experimental Medicine, Hepatogastroenterology Department, Prague, Czech Republic
,
Evzen Machytka
1   Institute for Clinical and Experimental Medicine, Hepatogastroenterology Department, Prague, Czech Republic
› Author Affiliations
 

A 57-year-old patient with arterial hypertension, dyslipidemia, and obesity grade I (BMI 34.9 kg/m2, 95 kg, 165 cm) underwent a new and unique sleeve gastroplasty procedure for weight reduction ([Video 1]).

Video 1 Endoscopic sleeve gastroplasty using a novel device.


Quality:

A novel device is used to perform the sleeve gastroplasty ([Fig. 1]). The specialized device is inserted into the patient through an overtube, and a thin nasal endoscope is passed through the device into the stomach. Under visual guidance, the appropriate position in the stomach (antrum) is identified, and a vacuum (–84 kPa) is initiated. Subsequently, the nasal endoscope is removed, and the device channel is closed to maintain the vacuum. In this phase of the procedure, full-thickness suturing of the gastric wall is performed using a circular stitch ([Fig. 2]). The device automatically terminates the stitch, and it is withdrawn through the overtube. The sutures are then inspected using an endoscope. This process is repeated 4–5 times, depending on the appearance of the sleeve gastroplasty. After completing all 4–5 sutures, the resulting sleeve is inspected, including checking for possible complications such as bleeding or perforation. The procedure is performed under general anesthesia, with observation continuing until the following day. The average duration of the procedure is 40 minutes.

Zoom Image
Fig. 1 Device overview.
Zoom Image
Fig. 2 Assembled device.

After three months, the patient achieved a weight loss of 8 kg (8.4 % total body weight loss) without any signs of complications. This novel device appears to be a promising new method for weight reduction that is fast, feasible, and safe ([Fig. 3]). Randomized studies comparing its effectiveness to other devices intended for endoscopic sleeve gastroplasty, where the percentage of total body weight loss at 6 months averages around 15 %, are now needed [1].

Zoom Image
Fig. 3 Device introduction via overtube.

Endoscopy_UCTN_Code_TTT_1AO_2AN

Endoscopy E-Videos
https://eref.thieme.de/e-videos

E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/).

This section has its own submission website at https://mc.manuscriptcentral.com/e-videos

Correction

Correction: Cutting-edge novel device in the treatment of obesity
Kral J, Selucka J, Waloszkova K et al. Cutting-edge novel device in the treatment of obesity.
Endoscopy 2023; 55: 155–156, DOI 10.1055/a-2209-3374.
In the above-mentioned article, the statement for the conflict of interest has been corrected. Correct is: The E-Video was supported by Nitinotes, the company that developed this device. This was corrected in the online version on March 21, 2024.


#

Competing interests

The E-Video was supported by Nitinotes, the company that developed this device.


Corresponding author

Jan Kral, MD, PhD, MBA
Institute for Clinical and Experimental Medicine
Videnska 1958/9
140 21 Prague 4
Czech Republic

Publication History

Article published online:
30 January 2024

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany


Zoom Image
Fig. 1 Device overview.
Zoom Image
Fig. 2 Assembled device.
Zoom Image
Fig. 3 Device introduction via overtube.